United States Neuroscience Antibodies and Assays Market 2031 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth

Neuroscience antibodies and assays market is growing at a CAGR of 14.5% during the forecast period (2024-2031).

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/neuroscience-antibodies-and-assays-market?sb

Key Development:

United States: Recent Neuroscience Antibodies & Assays Developments

✅ In December 2025, Manifold Bio announced a strategic collaboration with Roche to co‐develop next‐generation antibody‐based blood‐brain‐barrier (BBB) brain shuttles aimed at neurological disease targets, backed by a multi‐billion‐dollar commitment to AI‐guided design of CNS therapeutic antibodies.

✅ In November 2025, Eli Lilly signed a substantial licensing and joint research agreement with ABL Bio worth approximately $2.6 billion to advance bispecific antibodies targeting neurological indications, significantly boosting U.S. antibody innovation for CNS therapies.

✅ In October 2025, Novartis agreed to acquire Avidity Biosciences in a definitive ~$12 billion deal, bringing Avidity's antibody‐oligonucleotide conjugate platform which includes neuromuscular and CNS‐relevant modalities into the Novartis neuroscience pipeline.

✅ In June 2025, Roche advanced its anti‐alpha‐synuclein investigational antibody, prasinezumab, into Phase III development for early‐stage Parkinson's disease after promising Phase II data, marking a major clinical progress milestone in antibody‐based neurodegeneration therapy development.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=neuroscience-antibodies-and-assays-market

Japan: Recent Neuroscience Antibodies & Assays Developments

✅ In December 2025, Ther is a significant momentum in Japan's neuroscience antibody market driven by growth in Alzheimer's and Parkinson's diagnostics and rising demand for high‐performance neurodegenerative assays, with local players expanding offerings.

✅ In October 2025, Japan research consortia including Tokyo institutions reported novel antibody discoveries targeting synaptic proteins to deepen understanding of depression and anxiety disorders, catalyzing advanced assay applications in fundamental neuroscience research.

✅ In July 2025, Japanese pharmaceutical labs launched new commercial antibody kits tailored for dementia research optimized for high‐throughput screening, enabling expanded biomarker evaluation by local academic and biotech labs.

Key Players:

=> Thermo Fisher Scientific, Bio-Rad Laboratories, Inc, Merck KGaA, F. Hoffmann-La Roche, Cell Signaling Technology, Inc, BioLegend, Inc, Abcam Plc, Rockland Immunochemicals, Inc, GenScript, Santa Cruz Biotechnology, Inc

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/neuroscience-antibodies-and-assays-market?sb

Key Segments:

By Product Type

Consumables dominate with 55% share, driven by frequent usage in diagnostic workflows, reagent kits, and laboratory testing across pharmaceutical and research sectors. Instruments account for 45%, supported by demand for advanced diagnostic devices, automation solutions, and analytical equipment in laboratories and clinical research facilities.

By Technology

Immunoassays/Immunochemistry lead with 48% share, fueled by widespread applications in clinical diagnostics, biomarker detection, and pharmaceutical R&D. Molecular diagnostics hold 35%, supported by adoption in genetic testing, infectious disease detection, and personalized medicine. Other technologies account for 17%, including emerging platforms, hybrid assays, and innovative diagnostic techniques.

By End-User

Pharmaceutical and biotechnology companies lead with 50% share, driven by ongoing drug development, clinical trials, and diagnostic R&D. Academic and research institutes account for 30%, supported by growing research activities, laboratory expansion, and funding for scientific studies. Other end-users hold 20%, including hospitals, diagnostic centers, and specialty labs.

By Region

North America - 38% Share
North America leads with 38%, fueled by advanced laboratory infrastructure, high R&D expenditure, and strong adoption of diagnostic consumables and instruments in the U.S. and Canada.

Europe - 27% Share
Europe holds 27%, driven by pharmaceutical and biotech hubs, stringent regulatory standards, and demand for cutting-edge diagnostic solutions in Germany, the U.K., France, Italy, and Spain.

Asia Pacific - 25% Share
Asia Pacific accounts for 25%, supported by rising healthcare infrastructure, expansion of research institutes, and increasing demand for molecular and immunoassay diagnostics in China, India, Japan, and Southeast Asia.

Latin America - 6% Share
Latin America holds 6%, driven by growth in pharmaceutical research, diagnostic laboratories, and biotech adoption across Brazil, Mexico, and Argentina.

Middle East & Africa - 4% Share
Middle East & Africa represent 4%, supported by emerging R&D activities, increasing laboratory investments, and gradual adoption of advanced diagnostic technologies in GCC countries, South Africa, and North Africa.

FAQ

Q: What is the growth rate of the Neuroscience antibodies and assays Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 14.5% during the forecast period from 2024 to 2031.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.